| Literature DB >> 24988292 |
Jost B Jonas1, Ningli Wang2, Ya Xing Wang3, Qi Sheng You3, Diya Yang2, Liang Xu3.
Abstract
PURPOSE: To examine characteristics of ocular hypertensive subjects and potential associations with estimated cerebrospinal fluid pressure (estCSFP).Entities:
Mesh:
Year: 2014 PMID: 24988292 PMCID: PMC4079553 DOI: 10.1371/journal.pone.0100533
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Bland-Altman Plot Showing the Distribution of the Mean of the Calculated Cerebrospinal Fluid Pressure (CSFP) and Measured CSFP Versus the Mean Difference of Measured CSFP – Calculated CSFP.
Demographic Data and Measurements (Mean ± Standard Deviation) of Ocular Hypertensive Subjects and Ocular Normotensive Subjects with Normal Optic Nerve in the Beijing Eye Study 2011.
| Parameter | Ocular Hypertensive Group | Normotensive Group |
|
| N | 62 | 2757 | |
| Age (Years) | 63.3±8.8 | 63.7±9.5 | 0.73 |
| Rural Region/Urban region | 42/20 | 1327/1430 | 0.003 |
| Men/Women | 30/32 | 1182/1575 | 0.44 |
| Body Mass Index (kg/m2) | 26.6±4.2 | 25.6±3.8 | 0.07 |
| Body Height (cm) | 162±9 | 162±8 | 0.90 |
| Blood Concentration Glucose (mmol/L) | 6.41±2.49 | 5.69±1.52 | 0.04 |
| Glycosylated Hemoglobin (%) | 4.69±1.48 | 4.36±0.95 | 0.10 |
| Blood Concentration Cholesterol (mmol/L) | 5.26±1.24 | 5.08±1.02 | 0.30 |
| Blood Concentration High-Density Lipoproteins (mmol/L) | 1.41±0.50 | 1.45±0.46 | 0.59 |
| Blood Concentration Low-Density Lipoproteins (mmol/L) | 3.52±1.06 | 3.37±0.92 | 0.32 |
| Blood Concentration Triglycerides (mmol/L) | 2.24±2.09 | 1.75±2.64 | 0.10 |
| Systolic Blood Pressure (mm Hg) | 140±23 | 130±21 | 0.001 |
| Diastolic Blood Pressure (mm Hg) | 76±12 | 70±12 | 0.001 |
| Pulse | 74.8±11.8 | 72.3±10.0 | 0.10 |
| Arterial Hypertension (%) | 72.6±5.7 | 52.4±1.0 | 0.002 |
| Treatment of Arterial Hypertension | 52.5±6.4 | 40.5±0.9 | 0.07 |
| Diabetes mellitus (%) | 23.6±5.8 | 19.2±0.8 | 0.39 |
| Cognitive Function Score | 26.2±3.6 | 26.5±3. | 0.44 |
| Estimated Cerebrospinal Fluid Pressure (mm Hg) | 10.5±3.6 | 9.0±3.7 | 0.003 |
| Intraocular Pressure (Corrected) (mm Hg) | 22.5±2.1 | 14.4±2.3 | <0.001 |
| Trans-Lamina Cribrosa Pressure Difference (Corrected) (mm Hg) | 12.0±4.4 | 5.4±3.8 | <0.001 |
| Retinal Nerve Fiber Layer Thickness (µm) | 100±9 | 103±10 | 0.02 |
| Refractive Error (Diopter) | 0.23±1.59 | −0.04±1.70 | 0.48 |
| Central Corneal Thickness (µm) | 532±39 | 532±32 | 0.99 |
| Anterior Corneal Curvature Radius (mm) | 7.62±0.26 | 7.61±0.25 | 0.87 |
| Anterior Chamber Depth (mm) | 2.33±0.35 | 2.48±0.46 | 0.30 |
| Lens Thickness (mm) | 4.64±0.27 | 4.56±0.33 | 0.12 |
| Axial Length (mm) | 22.9±1.2 | 23.2±0.97 | 0.29 |
Figure 2Boxplot showing the distribution of the estimated cerebrospinal fluid pressure in the ocular hypertensive subjects and normal subjects in the Beijing Eyes Study 2011.
Figure 3Boxplot showing the distribution of the estimated trans-lamina cribrosa pressure difference in the ocular hypertensive subjects and normal subjects in the Beijing Eyes Study 2011.
Multivariate Analysis of the Associations between the Presence of Ocular Hypertension and Systemic and Ocular Parameters in the Beijing Eye Study 2011.
| Parameter |
| Regression Coefficient B | Odds Ratio | 95% Confidence Interval |
| Estimated Cerebrospinal Fluid Pressure (mm Hg) | 0.03 | 0.08 | 1.08 | 1.01, 1.17 |
| Arterial Hypertension | 0.07 | 0.58 | 1.79 | 0.96, 3.34 |
| Retinal Nerve Fiber Layer Thickness (µm) | 0.03 | −0.03 | 0.97 | 0.95, 0.997 |
| Blood Concentration Glucose (mmol/L) | 0.006 | 0.15 | 1.17 | 1.04, 1.30 |